N.C. Gen. Stat. § 90-85.21D
Dialysis facilities as designated agents to receive home medications for patients with renal failure
Redline — June 1, 2021 → current.View current text →
Current — April 1, 2022
As of June 1, 2021
Pharmacies may ship medications for home use by patients with renal failure to renal dialysis facilities for delivery to (i) patients who receive dialysis treatments in a Medicare certified dialysis facility or (ii) patients who self-dialyze at home, provided that all of the following criteria are met:
Pharmacies may ship medications for home use by patients with renal failure to renal dialysis facilities for delivery to (i) patients who receive dialysis treatments in a Medicare certified dialysis facility or (ii) patients who self-dialyze at home, provided that all of the following criteria are met:
(1) The patient authorizes, in writing, the dialysis facility staff to act as the patient's designated agent for the purpose of receiving mailed medical packages at the dialysis facility.
(1) The patient authorizes, in writing, the dialysis facility staff to act as the patient’s designated agent for the purpose of receiving mailed medical packages at the dialysis facility.
(2) The pharmacy, whether in-state or out-of-state, is licensed as a pharmacy in North Carolina.
(2) The pharmacy, whether in-state or out-of-state, is licensed as a pharmacy in North Carolina.
(3) The medications for home use are dispensed by the licensed pharmacist pursuant to a valid prescription order.
(3) The medications for home use are dispensed by the licensed pharmacist pursuant to a valid prescription order.
(4) The delivered medication packages are held in a secure location in an area not accessible to the public and delivered by the dialysis facility staff, unopened, to the patient.
(4) The delivered medication packages are held in a secure location in an area not accessible to the public and delivered by the dialysis facility staff, unopened, to the patient.
(5) Medication packages are individually labeled with the patient name.
(5) Medication packages are individually labeled with the patient name.
(6) The medications exclude controlled substances, as defined under G.S. 90-87.
(6) The medications exclude controlled substances, as defined under G.S. 90-87.
History
(2015-28, s. 1.)
Official source: North Carolina General Assembly. Reproduced from public-domain North Carolina statutes; confirm against the official source for the current text. Not legal advice.